Wahyuri Wahyuri, U. Athiyah, Ira Puspitasari, Y. Nita
{"title":"用k -均值方法聚类药物抽样数据以确定药物分布模式:印度尼西亚加里曼丹省中部的研究","authors":"Wahyuri Wahyuri, U. Athiyah, Ira Puspitasari, Y. Nita","doi":"10.20473/jisebi.5.2.208-218","DOIUrl":null,"url":null,"abstract":"Background: Drug sampling and testing in the context of post-marketing control is an important component to ensure drug safety in the supply chains. The results are used by the Indonesian National Agency for Drug and Food Control (NA-FDC) for conducting public warnings, evaluating the Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) implementation, and enforcing the law against drug violation.Objective: This study aimed to identify and analyze drug distribution patterns to provide an overview of drug sampling in the public sector. Methods: The data was collected from Balai Besar Pengawas Obat dan Makanan (BBPOM) Palangka Raya’s database. The collected data were the drug sampling data from Integrated Information Reporting Systems (IIRS) application from 2014 to 2018. Next, we employed CRISP-DM methodology to analyze the data and to identify the pattern. K-means clustering model was selected for data modeling.Results: The dataset contained five attributes, i.e., drug name, therapeutic classes, district/city, sample category, and evaluation of drug surveillance. The drug distribution pattern formed three clusters. First cluster contained 522 drug items in eight therapeutic classes and spread over ten districts, second cluster contained 1542 drug items in five therapeutic classes and spread over five districts, and third cluster contained 503 drug items in eleven therapeutic classes and spread across nine districts.Conclusion: To conclude, the applied data mining technique has improved the decision on the drug sampling planning. It also provides in-depth information on the improvement of drug post-marketing control performance in Central Kalimantan Province.Keywords: Clustering, CRISP-DM, Data Mining, Drug distribution patterns, Drug quality control, Drug sampling","PeriodicalId":16185,"journal":{"name":"Journal of Information Systems Engineering and Business Intelligence","volume":"42 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Clustering of Drug Sampling Data to Determine Drug Distribution Patterns with K-Means Method : Study on Central Kalimantan Province, Indonesia\",\"authors\":\"Wahyuri Wahyuri, U. Athiyah, Ira Puspitasari, Y. Nita\",\"doi\":\"10.20473/jisebi.5.2.208-218\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Drug sampling and testing in the context of post-marketing control is an important component to ensure drug safety in the supply chains. The results are used by the Indonesian National Agency for Drug and Food Control (NA-FDC) for conducting public warnings, evaluating the Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) implementation, and enforcing the law against drug violation.Objective: This study aimed to identify and analyze drug distribution patterns to provide an overview of drug sampling in the public sector. Methods: The data was collected from Balai Besar Pengawas Obat dan Makanan (BBPOM) Palangka Raya’s database. The collected data were the drug sampling data from Integrated Information Reporting Systems (IIRS) application from 2014 to 2018. Next, we employed CRISP-DM methodology to analyze the data and to identify the pattern. K-means clustering model was selected for data modeling.Results: The dataset contained five attributes, i.e., drug name, therapeutic classes, district/city, sample category, and evaluation of drug surveillance. The drug distribution pattern formed three clusters. First cluster contained 522 drug items in eight therapeutic classes and spread over ten districts, second cluster contained 1542 drug items in five therapeutic classes and spread over five districts, and third cluster contained 503 drug items in eleven therapeutic classes and spread across nine districts.Conclusion: To conclude, the applied data mining technique has improved the decision on the drug sampling planning. It also provides in-depth information on the improvement of drug post-marketing control performance in Central Kalimantan Province.Keywords: Clustering, CRISP-DM, Data Mining, Drug distribution patterns, Drug quality control, Drug sampling\",\"PeriodicalId\":16185,\"journal\":{\"name\":\"Journal of Information Systems Engineering and Business Intelligence\",\"volume\":\"42 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-10-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Information Systems Engineering and Business Intelligence\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.20473/jisebi.5.2.208-218\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Information Systems Engineering and Business Intelligence","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20473/jisebi.5.2.208-218","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
摘要
背景:在上市后控制的背景下,药品抽样和检测是确保供应链中药品安全的重要组成部分。印度尼西亚国家药品和食品管理局(NA-FDC)使用这些结果进行公众警告,评估良好生产规范(GMP)和良好销售规范(GDP)的实施,以及执法打击毒品违法行为。目的:本研究旨在识别和分析药物分布模式,以提供公共部门药物抽样的概述。方法:数据来自Balai Besar Pengawas Obat dan Makanan (BBPOM) Palangka Raya数据库。收集的数据为2014 - 2018年综合信息报告系统(IIRS)申请的药品抽样数据。接下来,我们采用CRISP-DM方法分析数据并确定模式。采用K-means聚类模型进行数据建模。结果:该数据集包含药物名称、治疗类别、地区/城市、样本类别和药物监测评价5个属性。药品分布格局形成3个集群。第一聚类包含8个治疗类522种药物,分布在10个地区;第二聚类包含5个治疗类1542种药物,分布在5个地区;第三聚类包含11个治疗类503种药物,分布在9个地区。结论:数据挖掘技术的应用提高了药品抽样计划决策的准确性。它还提供了关于加里曼丹省中部药品上市后管制绩效改进的深入信息。关键词:聚类,CRISP-DM,数据挖掘,药品分布模式,药品质量控制,药品抽样
Clustering of Drug Sampling Data to Determine Drug Distribution Patterns with K-Means Method : Study on Central Kalimantan Province, Indonesia
Background: Drug sampling and testing in the context of post-marketing control is an important component to ensure drug safety in the supply chains. The results are used by the Indonesian National Agency for Drug and Food Control (NA-FDC) for conducting public warnings, evaluating the Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) implementation, and enforcing the law against drug violation.Objective: This study aimed to identify and analyze drug distribution patterns to provide an overview of drug sampling in the public sector. Methods: The data was collected from Balai Besar Pengawas Obat dan Makanan (BBPOM) Palangka Raya’s database. The collected data were the drug sampling data from Integrated Information Reporting Systems (IIRS) application from 2014 to 2018. Next, we employed CRISP-DM methodology to analyze the data and to identify the pattern. K-means clustering model was selected for data modeling.Results: The dataset contained five attributes, i.e., drug name, therapeutic classes, district/city, sample category, and evaluation of drug surveillance. The drug distribution pattern formed three clusters. First cluster contained 522 drug items in eight therapeutic classes and spread over ten districts, second cluster contained 1542 drug items in five therapeutic classes and spread over five districts, and third cluster contained 503 drug items in eleven therapeutic classes and spread across nine districts.Conclusion: To conclude, the applied data mining technique has improved the decision on the drug sampling planning. It also provides in-depth information on the improvement of drug post-marketing control performance in Central Kalimantan Province.Keywords: Clustering, CRISP-DM, Data Mining, Drug distribution patterns, Drug quality control, Drug sampling